Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-008902

President & CEO sold 5,466 shares at an average $23.49 ($128,373)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Warmuth Markus President & CEO 2026-01-07 Sale 10b5-1 −3,707 $23.24 $86,159 620,696 D
Warmuth Markus President & CEO 2026-01-07 Sale 10b5-1 −1,450 $23.88 $34,620 619,246 D
Warmuth Markus President & CEO 2026-01-07 Sale 10b5-1 −309 $24.57 $7,593 618,937 D
Open-market sales · 5,466 sh · avg $23.49 · $128,373
Loading xslF345X05/ownership.xml…